TW200511995A - Antifungal composition - Google Patents

Antifungal composition

Info

Publication number
TW200511995A
TW200511995A TW093110685A TW93110685A TW200511995A TW 200511995 A TW200511995 A TW 200511995A TW 093110685 A TW093110685 A TW 093110685A TW 93110685 A TW93110685 A TW 93110685A TW 200511995 A TW200511995 A TW 200511995A
Authority
TW
Taiwan
Prior art keywords
composition
fungi agent
morpholine series
antifungal composition
morpholine
Prior art date
Application number
TW093110685A
Other languages
English (en)
Inventor
Shigeki Sawamura
Original Assignee
Kobayashi Seiyaku Kabushiki Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kobayashi Seiyaku Kabushiki Kaisha filed Critical Kobayashi Seiyaku Kabushiki Kaisha
Publication of TW200511995A publication Critical patent/TW200511995A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
TW093110685A 2003-09-30 2004-04-16 Antifungal composition TW200511995A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003341729A JP2005104918A (ja) 2003-09-30 2003-09-30 抗真菌組成物

Publications (1)

Publication Number Publication Date
TW200511995A true TW200511995A (en) 2005-04-01

Family

ID=34419219

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093110685A TW200511995A (en) 2003-09-30 2004-04-16 Antifungal composition

Country Status (3)

Country Link
JP (1) JP2005104918A (zh)
TW (1) TW200511995A (zh)
WO (1) WO2005032557A1 (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3800232B2 (ja) * 2004-09-30 2006-07-26 小林製薬株式会社 抗真菌性外用組成物
JP5097363B2 (ja) 2006-06-05 2012-12-12 小林製薬株式会社 抗真菌組成物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60215092A (ja) * 1984-04-09 1985-10-28 Kao Corp 人体塗布用粉末エアゾ−ル組成物
JPH0688897B2 (ja) * 1989-04-28 1994-11-09 久光製薬株式会社 エアゾール製剤
JPH0812964A (ja) * 1994-07-01 1996-01-16 Kobayashi Pharmaceut Co Ltd 粉末エアゾール組成物
JP4253047B2 (ja) * 1996-09-27 2009-04-08 杏林製薬株式会社 被膜形成性抗真菌剤組成物
JPH11106332A (ja) * 1997-08-07 1999-04-20 Taisho Pharmaceut Co Ltd 粉末エアゾール製剤
JP2001226258A (ja) * 1999-12-06 2001-08-21 Taisho Pharmaceut Co Ltd 粉末エアゾール組成物
JP4814414B2 (ja) * 2000-05-26 2011-11-16 大正製薬株式会社 抗真菌液剤組成物
JP2002284702A (ja) * 2001-01-19 2002-10-03 Teika Seiyaku Kk 外用抗真菌製剤
JP2002363101A (ja) * 2001-04-03 2002-12-18 Taisho Pharmaceut Co Ltd 外用剤

Also Published As

Publication number Publication date
WO2005032557A1 (ja) 2005-04-14
JP2005104918A (ja) 2005-04-21

Similar Documents

Publication Publication Date Title
GEP20094847B (en) Novel phenyl-propargylether derivatives
TW200514772A (en) Novel tetrahydropyridine derivatives
EP0919225A3 (en) Lipid mix for lip product
CY1115825T1 (el) Φαρμακευτικες συνθεσεις που περιεχουν λεβετιρακεταμη και διαδικασια παρασκευης τους
WO2005044234A3 (en) Nanoparticulate compositions having a peptide as a surface stabilizer
BRPI0415121A (pt) material particulado, forma de dosagem sólida, método para fabricar a mesma, e, uso de um material particulado ou de uma forma de dosagem sólida
BR0313387A (pt) Composições antimicrobianas
WO2001090091A8 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
ECSP045378A (es) Derivados novedosos de diazabiciclononeno
WO2004113297A3 (en) Aza-ring derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
TW200621773A (en) Bicyclononene derivatives
WO2005030209A8 (en) Pyridine derivatives and use thereof as urotensin ii antagonists
MXPA05011498A (es) Derivados de 9-azabiciclo[3.3.1]non-6-eno con un heteroatomo en la posicion 3 como inhibidores de renina.
MXPA05011711A (es) Derivados de diazabiciclononeno.
MXPA05011496A (es) Derivados de azabiciclononeno.
TW200628468A (en) Bicyclononene derivatives
WO2005054244A3 (en) Azabicyclooctene and other tetrahydropyridine derivatives with a new side-chain
HK1090354A1 (en) Novel dibenzo [b,f]oxepine-10-carboxamides and pharmaceutical uses thereof
WO2009055084A3 (en) Vitamin c compositions
MXPA05011497A (es) Derivados de tropano y su uso como inhibidores de la enzima de conversion de angiotensina (ace).
HK1090062A1 (en) Colchicoside analogues
WO2005006860A3 (en) Azole derivatives and methods for making the same
TW200511995A (en) Antifungal composition
TW200628167A (en) Composition for preventing and/or treating metabolic syndrome and insulin resistance syndrome
TW200511986A (en) Antifungal composition